The World Health Organization's Response to Emerging Human Immunodeficiency Virus Drug Resistance and a Call for Global Action.
J Infect Dis
; 216(suppl_9): S801-S804, 2017 12 01.
Article
en En
| MEDLINE
| ID: mdl-29040686
ABSTRACT
The global community, including the World Health Organization (WHO), has committed to ending the AIDS epidemic and to ensuring that 90% of people living with human immunodeficiency virus (HIV) are diagnosed, 90% start treatment, and 90% achieve and maintain virological suppression. The emergence of HIV drug resistance (HIVDR) as antiretroviral treatment programs expand could preclude the 90-90-90 targets adopted by the United Nations General Assembly at the High-Level Meeting on Ending AIDS from being achieved. The Global Action Plan on HIVDR is a call for collective action grounded on normative guidance providing a standardized and robust approach to monitoring, preventing, and responding to HIVDR over the next 5 years (2017-2021). WHO is committed to supporting country, global, regional, and national partners to implement and monitor the progress of the Global Action Plan. This article outlines the key components of WHO's strategy to tackle HIVDR and the role the organization takes in leading the global response to HIVDR.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Organización Mundial de la Salud
/
Infecciones por VIH
/
VIH
/
Fármacos Anti-VIH
Tipo de estudio:
Guideline
/
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
J Infect Dis
Año:
2017
Tipo del documento:
Article